期刊文献+

CD4、CCR5、CXCR4和DC-SIGN分子在HIV-1感染者及正常人晚孕胎盘及早孕绒毛的表达 被引量:1

Expression of CD4,CCR5,CXCR4 and DC-SIGN in chorionic villi and human placentae with or without HIV-1 infection
原文传递
导出
摘要 目的明确CD4、CCR5、CXCR4和DC-SIGN分子在HIV-1不同感染状态晚孕胎盘和早孕绒毛的存在及表达情况,为探索HIV-1宫内传播的分子机制提供理论依据。方法收集11例HIV-1感染孕妇胎盘、13例正常孕妇胎盘和10例早孕流产绒毛,免疫组化检测并比较3组孕妇胎盘或绒毛组织中HIV-1相关受体CD4、CCR5、CXCR4和DC-SIGN分子的存在情况及其表达强度。结果 CD4在早孕绒毛和晚孕胎盘中的表达存在个体差异,早孕组、对照组和病例组CD4阳性率分别为70.00%、61.54%、72.73%,3组阳性率差异无统计学意义(P=0.902)。CCR5、CXCR4和DC-SIGN分子在胎盘均有表达,均定位于滋养细胞和绒毛间质细胞和/或Hofbauer细胞,且在早孕绒毛中的表达强度均低于晚孕胎盘组,差异均有统计学意义(t1=-4.09,P1<0.001;t2=-4.80,P2<0.001;t3=-4.57,P3=0.001)。结论胎盘组织中存在多种HIV-1受体相关分子,具备感染的分子基础。胎盘滋养细胞上是否存在CD4分子具有个体差异;CCR5、CXCR4和DC-SIGN分子在晚孕胎盘中的表达高于早孕的绒毛,可能是HIV-1感染宫内传播多发生于孕晚期的原因之一。 Objective To investigate the expression of HIV-1 receptors CD4,co-receptors CCR5,CXCR4 and DC-SIGN in human placenta and chorionic villi and to explore the mechanism of in-utero transmission of human immunodeficiency virus type 1(HIV-1).Methods 11 placentas from HIV-1 seropositive women,13 placentas from normal placentas and 10 cases of early pregnancy abortion villi were collected.Immunohistochemistry method was used to detect the expression of CD4,CCR5,CXCR4 and DC-SIGN.Results There were individual differences of CD4 expression in placenta,the positive rate of the three groups was 70.00%,61.54% and 72.73%,respectively.There was no statistical difference among three groups.All of CXCR4,CCR5,and DC-SIGN had positive expression in the placenta,they all located at the trophoblast cells and stromal of villi.The level of CXCR4,CCR5,and DC-SIGN expression in chorionic villi from first trimester were lower than those in placentas from the third trimester,the difference among the three groups was significant(t1=-4.09,P1〈0.001;t2=-4.80,P2〈0.001;t3=-4.57,P3=0.001).Conclusions With the expression of CD4,CCR5,CXCR4 and DC-SIGN,placenta possessed the molecular basis of HIV-1 infection.There are individual differences in the expression of CD4 molecules in trophoblast cells.The expressions of CCR5,CXCR4 and DC-SIGN molecules in the placenta from the third trimester were higher than those in chorionic villi from first trimester,which might be related with the fact that most of MTCT occurred at the third trimester stage.
出处 《中华疾病控制杂志》 CAS 北大核心 2012年第8期643-646,共4页 Chinese Journal of Disease Control & Prevention
基金 广东省自然科学基金(1045106320100624)
关键词 HIV-1 胎盘 抗原 CD4 受体 CCR5 受体 CXCR4 HIV-1; Placenta; Antigens,CD4; Receptors,CCR5; Receptors,CXCR4
  • 相关文献

参考文献12

  • 1UNAIDS. AIDS Epidemic Update : December 2009 [ M ]. Copen- hagen: WHO Regional Office Europe, 2009.
  • 2中华人民共和国卫生部.中国艾滋病防治联合评估报告(2007年)[EB/OL].(2007-11-29)[2012-02-03].http://www.china.(20111.cn/policy/txt/2007-12/04/content-9342505.htm.
  • 3梁科,桂希恩,张元珍,荣玉萍,严亚军.HIV阳性孕产妇的发现时机及接受阻断情况分析[J].中华疾病控制杂志,2009,13(4):445-447. 被引量:4
  • 4Zhang Z, Schuler T, Zupancic M, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells [J]. Science, 1999,286(5443) :1353-1357.
  • 5Cilliers T, Nhlapo J, Coetzer M, et al. The CCR5 and CXCR4 eoreeeptora are both used by human immunodefieieney virus type 1 primary isolates from subtype C [J]. J Virol, 2003,77(7) :4449- 4456.
  • 6Cambi A, de Lange F, van Maarseveen NM, et al. Microdomains of C-type lectin DC-SIGN are portals for virus entry into dendritic cells [J]. J Cell Biol, 2004,164( 1 ) :145-155.
  • 7申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:398
  • 8Mognetti B, Moussa M, Croitoru J, et al. HIV-1 co-receptor ex- pression on trophoblastie cells from early placentas and permissivity to infection by several HIV-1 primary isolates [ J]. Clin Exp Im- munol, 2000,119 ( 3 ) :486-492.
  • 9Kolohinsky P, Kiprilov E, Bartley P, et al. Loss of a single N- linked glycan allows CIM-independent human immunodeficiency virus type 1 infection by altering the position of the gpl20 V1/V2 variable loops i J ]. J Virol, 2001,75 (7) : 3435-3443.
  • 10Fujii N, Nakashima H, Tamamura H. The therapeutic potential of CXCR4 antagonists in the treatment of HIV [J]. Expert Opin Investig Drugs, 2003,12 ( 2 ) : 185-195.

二级参考文献11

  • 1申洪,陆药丹.免疫组织化学染色的定量方法研究[J].生物医学工程学杂志,1993,10(4):281-284. 被引量:127
  • 2Thorne C, Newell ML. Mother-to-child transmission of HIV infection and its prevention [ J ]. Curr HIV Res, 2003,1 (4) : 447- 462.
  • 3Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial [J]. JAMA, 2002,288(2) : 189-98.
  • 4Luzuriaga K, Sullivan JL. Prevention of mother-to-child transmission of HIV infection [J]. Clin Infect Dis, 2005,40(3) :466- 467.
  • 5Zaba BW, Carpenter LM, Boerma JT, et al. Adjusting ante-natal clinic data for improved estimates of HIV prevalence among women in sub-Saharan Africa [J]. AIDS, 2000,14(17) :2741-2750.
  • 6Yahya-Malima KI, Olsen BE, Matee MI, et al. The silent HIV epidemic among pregnant women within rural Northern Tanzania [J]. BMC Public Health, 2006,6 : 109.
  • 7World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infant (2004) [EB/ OL]. http://www.who. int/hiv/pub/mtct/en/arvdrugswomenguidelinesfinal. pdf.
  • 8Bucceri AM, Somigliana E, Matrone R, et al. Combination antiretroviral therapy in 100 HIV-1-infected pregnant women [J]. Hum Reprod , 2002,17(2) :436-441.
  • 9Eshleman SH, Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving nevlrapine to prevent HIV-1 vertical transmission ( HIVNET012 ) [J]. AIDS, 2001,15(15) : 1951-1957.
  • 10申洪.免疫组织化学显色反应强度定量方法研究(Ⅱ)[J].细胞与分子免疫学杂志,1994,11(4):33-35. 被引量:52

共引文献400

同被引文献13

  • 1罗皓,梁浩,邵一鸣,张志勇,邢辉,沈菁,卢灿健.广西HIV-1重组流行株env基因V3-V4区序列变异分析[J].现代预防医学,2007,34(16):3028-3031. 被引量:2
  • 2Khamadi SA, Lihana RW, Mwaniki DL, et al. HIV type 1 genetic diversity in Moyale, Mandera and Turkana based on env-C2-V3 sequences [ J ]. AIDS Res Hum Retroviruses, 2008,24 ( 12 ) : 1561-1564.
  • 3Boonchawalit S, Jullaksorn D, Uttiyoung J, et al. Molecular evo- lution of HIV-1 CRF01 AE env in Thai patients [J]. PLoS One, 2011,6( 11 ) :e27098.
  • 4Hedskog C, Brodin J, Heddini A, et al. Longitudinal uhradeep characterization of HIV Type 1 R5 and X4 subpopulations in pa- tients followed from primary infection to coreceptor switch [ J ]. AIDS Res Hum Retroviruses, 2013,29 ( 9 ) : 1237-1244.
  • 5Padua E, Parreira R, Tendeiro R, et al. Potential impact of viral load and genetic makeup of HIV type 1 on mother-to-child tansmis- sion: charaterization of env-C2V3C3 and nef sequences [ J ]. AIDS Res Hum Retroviruses, 2009,25( 11 ) :1171-1177.
  • 6Stanfield RL, Gorny MK, Zolla-Pzner S, et al. Crystal structures of human immunodeficiency virus type 1 ( HIV-1 ) neutralizing an- tibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity [ J]. J Virol, 2006, 12(80) :6093-6105.
  • 7Gharu L, Ringe R, Pandey S, et al. HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop [ J ]. Virus Research, 2009,144: 306- 314.
  • 8Joshi A, Nyakeriga AM, Ravi R, et al. HIV ENV glycoprotein- mediated bystander apoptosis depends on expression of the CCR5 co-receptor at the cell surface and ENV fusogenic activity [ J ]. J Biol Chem, 2011,286(42 ) :36404-36413.
  • 9Arrildt KT, Joseph SB, Swanstrom R. The HIV-1 env protein: a coat of many colors [J]. Curr HIV/AIDS Rep, 2012,9( 1 ) :52- 63.
  • 10罗皓,梁浩,邵一鸣,张志勇,邢辉,沈菁,卢灿健.广西HIV-1毒株膜蛋白V3环氨基酸变异分析[J].实用预防医学,2008,15(1):11-16. 被引量:5

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部